This site uses cookies to ensure the best viewing experience for our readers.
The Thread Connecting Space Rockets, Fake News and Artificial Intelligence

The Thread Connecting Space Rockets, Fake News and Artificial Intelligence

All three domains experience a technological book, said Yonatan Adiri, the CEO of Israeli medical startup

Reut Shpigelman | 16:41  31.05.2018
According to Jonathan Adiri, founder and CEO of Israeli medical startup, there’s a thread connecting space rockets, fake news, and artificial intelligence: all are experiencing a technological boom, which has made them more advanced, and more affordable, than ever before, Mr. Adiri said. “We have reached an era in which the tech boom has caused a dramatic decline in costs,” he said.

For daily updates, subscribe to our newsletter by clicking here.

Mr. Adiri spoke on Tuesday to young entrepreneurs at an event hosted in Tel Aviv by Calcalist and Psagot Investment House Ltd. A former chief technology officer for late Israeli President Shimon Peres, in 2012, Mr. Adiri was nominated as a "Young Global Leader" by the World Economic Forum.

Jonathan Adiri. Photo: Amit Sha Jonathan Adiri. Photo: Amit Sha'al Jonathan Adiri. Photo: Amit Sha

Mr. Adiri discussed China’s heavy investment in artificial intelligence technologies. Facial recognition technologies are slowly replacing I.D.s in China, among a variety of other uses, Mr. Adiri said.

Related stories’s technology transforms regular smartphones into devices that perform medical urine analysis using computer vision algorithms, artificial intelligence, and the smartphones’ built-in camera. Using’s app, users can test for infections, chronic illnesses, and pregnancy-related complications. The company was founded in 2013 and is based in Tel Aviv.

In April, announced it has partnered with the American National Kidney Foundation and Pennsylvania-based Geisinger Health System to offer its smartphone-based urine tests at home. The three launched a clinical trial that month to test the technology among Geisinger’s patients.
share on facebook share on twitter share on linkedin share on whatsapp share on mail